Identifying primary site of lung-limited Cancer of unknown primary based on relative gene expression orderings

BMC Cancer

Table 2 Anti-lung cancer drugs and their target genes

Drug ID	Drug	FDA	Target genes
DB00317	Gefitinib	approved	EGFR
DB00361	Vinorelbine	approved	TUBB
DB00642	Pemetrexed	approved	TYMS, ATIC, DHFR, GART
DB05390	INS 316	investigational	P2RY2
DB08865	Crizotinib	approved	ALK, MET
DB08916	Afatinib	approved	EGFR, ERBB2, ERBB4
DB09063	Ceritinib	approved	ALK
DB09330	Osimertinib	approved	EGFR
DB09559	Necitumumab	approved	EGFR
DB11363	Alectinib	approved	ALK

ISSN: 1471-2407